Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma
Clinical trial NCT02054130 · COMPLETED
Trial details
- NCT number
- NCT02054130
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-13
- Primary completion
- 2016-12-12
- Enrollment
- 584
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.